摘要
仿制药的疗效最近在临床上遭到质疑,梯瓦制药公司因此发起了一项比较抗抑郁药安非他酮的仿制药与品牌药疗效的临床试验。仅靠生物等效性试验或许已经不能完全满足仿制药的审批。
Since the eff icacy of generic drugs has been questioned recently in clinical use,Teva Pharmaceuticals has launched a comparable clinical trial for the efficacy of generic and brand antidepressant bupropion. Bioequivalence testing alone may not fully satisfy the requirement for generic drug approval.
出处
《中国处方药》
2010年第1期14-14,共1页
Journal of China Prescription Drug